Lupin
Pharma segment is changing the track. Lupin above 200 DMA and consolidating in 4th wave. 50 and 100 DMA have given the cross on the upside. Resistance and 5th wave lies at 943-4.
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。